Jung Choi

Insider Reports History

Location
Brisbane, CA
Signature
/s/ Jennifer Lew, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jung Choi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Annexon, Inc. Director Common Stock 33,000 $138,270 $4.19 01 Dec 2025 By Trust
Annexon, Inc. Director Stock Option (Right to Buy) 55,000 05 Jun 2025 Direct
Global Blood Therapeutics, Inc. Officer Title: Chief Business and Strategy Officer Common Stock 0 $46.99 05 Oct 2022 By Trust
Global Blood Therapeutics, Inc. Officer Title: Chief Business and Strategy Officer Common Stock 0 $46.99 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Officer Title: Chief Business and Strategy Officer Restricted Stock Units 0 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Officer Title: Chief Business and Strategy Officer Stock Option (Right to Buy) 0 05 Oct 2022 Direct

Insider Reports Filed by Jung Choi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANNX Annexon, Inc. 01 Dec 2025 1 +$138,270 4 Director 03 Dec 2025, 16:30
ANNX Annexon, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:20
ANNX Annexon, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 21:43
ANNX Annexon, Inc. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:49
GBT Global Blood Therapeutics, Inc. 05 Oct 2022 16 $0 4 Officer Title: Chief Business and Strategy Officer 06 Oct 2022, 16:15
GBT Global Blood Therapeutics, Inc. 27 Sep 2022 11 +$699,994 4 Officer Title: Chief Business and Strategy Officer 29 Sep 2022, 20:43
GBT Global Blood Therapeutics, Inc. 01 Sep 2022 5 -$126,827 4 Officer Title: Chief Business and Strategy Officer 06 Sep 2022, 19:00
GBT Global Blood Therapeutics, Inc. 01 Aug 2022 4 -$68,882 4 Title: Chief Business and Strategy Officer 03 Aug 2022, 18:01
ANNX Annexon, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 16:34
GBT Global Blood Therapeutics, Inc. 01 Mar 2022 6 -$28,556 4 Officer Title: Chief Business and Strategy Officer 03 Mar 2022, 20:07
GBT Global Blood Therapeutics, Inc. 01 Feb 2022 5 -$97,962 4 Title: Chief Business and Strategy Officer 03 Feb 2022, 16:43
GBT Global Blood Therapeutics, Inc. 01 Sep 2021 4 -$37,773 4 Chief Business and Strategy Officer 03 Sep 2021, 20:01
GBT Global Blood Therapeutics, Inc. 01 Aug 2021 5 -$102,296 4/A Officer 24 Sep 2021, 19:00
ANNX Annexon, Inc. 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 17:11